Abstract:Pulmonary hypertension is a complicated and important pathological process in the development of a variety of cardiovascular and pulmonary diseases, and directly affects the development of the diseases and their prognosis. but its mechanisms are still not fully understood. Therefore, to clarify the mechanisms is an important task in this field. Nitric oxide (NO) and carbon monoxide (CO) have special significance in pulmonary circulation as compared with other organs for their special biological properties including continuous production, fast transmission and extensive action, etc, which attracts great attention in the life science research and initiates the new research field of gasotransmitters. Hydrogen sulfide (H2S), which has been recognized as a toxic gas, can be endogenously produced in the body. We considered it to be a new cardiovascular regulatory gasotransmitter based on the studies of its synthesis and distribution in cardiovascular system and cardiovascular effects under physiologic and pathophysiologic conditions. We found it exerted a general regulatory significance in cardiovascular diseases. Based on the research of the three gasotransmitters in hypoxic and high pulmonary blood flow-induced pulmonary hypertension, it was found that the dysfunction of the gasotransmitter pathways was involved in the pathogenesis of pulmonary hypertension and the supplement of gasotransmitters could alleviate pulmonary hypertension and pulmonary vascular remodeling. The mechanisms included that they could regulate vessel dilation, correct the imbalance between smooth muscle cell proliferation and apoptosis, inhibit the excess synthesis and stimulate the degradation of collagen, therefore inhibiting abnormal accumulation of collagen, etc. All these results indicated the significant regulatory effects of gasotransmitters in the pathogenesis of pulmonary hypertension.

Gaseous Signal Molecules and Pathogenesis of Pulmonary Artery Hypertension

Role of Gasotransmitters in the Pathogenesis of Pulmonary Hypertension

Epigenetic Regulation of Pulmonary Arterial Hypertension

[Significance of Gaseous Signal Molecule in the Pathogenesis of Cardiovascular Diseases].

A Newly Found Gasotransmitter, Hydrogen Sulfide, in the Pathogenesis of Hypertension and Other Cardiovascular Diseases

Gasotransmitters and the mechanisms for cardiovascular diseases

Impact of Hydrogen Sulfide on Carbon Monoxide/heme Oxygenase Pathway in the Pathogenesis of Hypoxic Pulmonary Hypertension

Molecular Targets of the Warburg Effect and Inflammatory Cytokines in the Pathogenesis of Pulmonary Artery Hypertension.

Advances in the research of sulfur dioxide and pulmonary hypertension

The Role and Mechanism of Gut Microbiota in Pulmonary Arterial Hypertension

Implications of Hydrogen Sulfide in Development of Pulmonary Hypertension

Gasotransmitter Research Advances in Respiratory Diseases.

Molecular Characterization and Elucidation of Pathways to Identify Novel Therapeutic Targets in Pulmonary Arterial Hypertension

From Nitric Oxide to Hyperbaric Oxygen

Hydrogen Sulfide Metabolism and Pulmonary Hypertension

New Insights Into Heat Shock Protein 90 in the Pathogenesis of Pulmonary Arterial Hypertension

From Nitric Oxide to Hyperbaric Oxygen: Invisible and Subtle but Nonnegligible Gaseous Signaling Molecules in Acute Pancreatitis.

Clinical Significance Of The Sympathetic Nervous System In The Development And Progression Of Pulmonary Arterial Hypertension

Therapy for Pulmonary Arterial Hypertension: Glance on Nitric Oxide Pathway

15-Lipoxygenase And 15-Hydroxyeicosatetraenoic Acid Regulate Intravascular Thrombosis In Pulmonary Hypertension

Advances in the Study of Inhaled Formulations for the Treatment of Pulmonary Arterial Hypertension